by Dr. Scholz and Dr. Lam - DVDs
Dr. Mark Scholz and Dr. Richard Lam have graciously made available
DVDs created from talks they have made to support groups. Prostate
Oncology Specialists is a medical group exclusively devoted to
caring for men with prostate cancer.
You may request free copies below. Please share them with your support
group or with friends who are dealing with prostate cancer. We
offer the DVDs for free, because we donâ€™t want men who might
benefit from the information to avoid requesting it simply because
If you would like to help defer our cost, so that we can continue
to offer such resources, please consider a generous donation to the
today. To donate
to PCRI, see our Donations
A New Perspective: Look Before You Leap -Mark Scholz,
Prostate cancer treatment is rapidly changing. More and more, the
disease is being separated into two widely disparate categories:
a chronic form that is not life-threatening and an aggressive type
requires combination treatment.
This lecture, by Mark Scholz, MD,
focuses on the chronic form of the disease, describing how men can
safely forgo immediate radical
This is achieved by a process of close monitoring called Active Surveillance.
A third type of prostate cancer falls between the two extremes of
chronic and aggressive—it is called intermediate risk. Management
of Intermediate Risk prostate cancer with Testosterone Inactivating
(TIP) instead of radical therapy is also covered in this lecture.
Systemic Treatments for Prostate Cancer -Richard
Why are medicines for a “localized” cancer needed?
Prostate cancer, contrary to popular belief, is often associated with
systemic metastasis—microscopic cancer outside of the gland.
Clear bone scans and CT scans can be misleading since they are unable
to “see” microscopic disease. Microscopic metastasis
may be present if the PSA is rising quickly, multiple biopsy cores
involved with cancer, the Gleason score is greater than 7, the PSA
is above 10, or a large nodule is present in the prostate. Men with
these adverse risk features receive little, if any benefit when primary
therapy consists of prostate surgery or radiation alone.
This lecture, by Richard Lam, MD, focuses on identifying men likely
to have micro-metastasis and discusses possible treatments. Systemic
therapies include testosterone inactivating pharmaceuticals (TIP),
radiation therapy, Taxotere® (docetaxel), immune-based compounds,
targeted drugs, and experimental agents.
Testosterone Independent Prostate Cancer -Mark Scholz,
Testosterone blockade can control prostate cancer for years. However,
when the disease becomes resistant, additional therapy is required.
Timing can be crucial—it is important to avoid delaying therapy.
Early initiation of treatment increases its effectiveness.
This lecture, by Mark Scholz, MD, explains how to spot the first
signs of testosterone resistance so that treatment can start
immediately. The principles and proper methods for selecting appropriate
are reviewed. Methods for reducing the side-effects of treatment
for handling common emergencies are addressed.
You can order these DVDs online by using this